EVA WAY Foundation

Strengthening Rare Disease Patient Organizations for a Brighter Future

There is no delight in owning anything unshared.
Lucius Annaeus Seneca

The EVA WAY Foundation, founded by Eva Portmann, is dedicated to helping rare disease patient organizations succeed. By leveraging expertise in scientific research, advanced programming, and organizational development, we aim to help these groups amplify their voices and achieve their goals with confidence while remaining autonomous.

Rare diseases affect over 8,000 conditions and impact 5% of the population when taken together.

We are seeking to support patient organizations ready to tackle projects that require scientific, technical, or organizational support. We support individual projects up to CHF 50'000. Our Advisory Team reviews applications biannually, in April and October.

How to Apply

Submit a brief application detailing your project and financing plan (deadlines March 1 & September 1).
If eligible, you will be invited to submit additional information.
Full review: Applications are carefully evaluated. Please be patient during this process.
You will receive an email about the foundation advisory team’s decision. Note: We do not provide justifications for rejections.
Approved projects are expected to maintain transparency and professionalism throughout.

Check if your organization qualifies and apply today!

EVA WAY Foundation's Advisory Team

	Prof. Dr. med. Johannes Roth Chief Center for Rare Diseases Luks and Children's Hospital of Central Switzerland
	Prof. Dr. Marc Pouly Co-Head Applied AI Research Lab Hochschule Luzern
	Elisabeth Hoechsmann Former Exec Director Compliance & Business Ethics
	Eva Portmann Founder & CEO of EVA WAY AG

Note

The EVA WAY foundation was setup as a sub-foundation of the Rütli Stiftung (https://ruetli-stiftung.ch/). We have no political, religious or ethical affiliations. It is also tax-exempt in Switzerland and is monitored by the Swiss Federal Supervisory Board.

EVA WAY Foundation

How to Apply

EVA WAY Foundation's Advisory Team

Note

Call me

Send me an email

Connect